share_log
Reuters ·  Jan 28 12:00
Seed Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Lead Oncology Asset Rbm39 Degrader and Enters Strategic Transactions With New Investors
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 401

Recommended

Write a comment